Today we released a new iOS and Android application, this is a massive product update and we can’t wait for you to start using these new fresh apps in your research.
Our app historically was designed for cross-sectional research and the collection of surveys that did not involve tracking of subjects across time. This has changed now. You may now choose from two different study designs on Teamscope:
Create cases and store data for them longitudinally, do this the Teamscope way, fully collaboratively.
We have redesigned our form (eCRF) builder, choose among different field types.
You may rearrange fields now by dragging them.
The quality of your research is only as strong as your data integrity. We have implemented new conditions on the form builder, add skip logic and input validation to your field.
Create complex validation rules.
Teamscope is now fully compliant with Good Clinical Practice.
GCP is a process that includes established ethical and scientific quality standards for the design, conduct, recording and reporting of clinical research involving the participation of human subjects. Compliance with GCP provides public assurance that the rights, safety, and well-being of research subjects are protected and respected, consistent with the principles enunciated in the Declaration of Helsinki and other internationally
recognized ethical guidelines, and ensures the integrity of clinical research data. (World Health Organization).
Teamscope now offers strong data validation and protection with data ranges, audit trails, and encryption making your study data high quality and GCP compliant.
In the following weeks, we will continue to increase the capability of our web platform, we will roll out more field types and conditions and take further steps in case management, stay tuned! :)
Got a feature request? Please don't hesitate to send us a message: firstname.lastname@example.org
Build fully customizable data capture forms, collect data wherever you are and analyze it with a few clicks — without any training required.